Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CMMBCMMB
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CHEMOMAB THERAPEUTICS LTD

CITADEL ADVISORS LLC holds 95,311 shares of CMMB (CHEMOMAB THERAPEUTICS LTD), worth $154,404 as of 2026-Q2. The position was increased (+48.5% shares).

Current Value

$154,404

Current Shares

95,311

Total Value Change

-$16,835

Total Shares Change

-8,470

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
95,311
+48.5%
$154,4040.0%$1.62
21
2026-Q1
Decreased
64,182
-38.2%
$100,7660.0%$1.79
0
2025-Q4
New
103,781
-
$171,2390.0%$1.64
35

Other major holders of CMMB: MORGAN STANLEY, JANE STREET GROUP, LLC, RHUMBLINE ADVISERS, XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used